48North Cannabis Corp. (“48North” or “the Company”) (TSXV: NRTH) is pleased to announce that it is has completed the planting of its first outdoor cannabis crop at its Good:Farm, Canada’s largest outdoor organic cannabis cultivation facility (3.7 million sq. ft. of cultivation space) in Brant County, Ont.
48North has successfully planted more than 250,000 cannabis seeds at Good:Farm. At the farm, 48North has planted 10 unique cultivars proven to be successfully grown outdoors; both high-THC and high-CBD strains were selected for planting. The Company expects two harvests annually at the Good:Farm. The first harvest is planned for late-August and will be exclusively the Company’s auto-flowering strains; the second harvest, of photoperiod plants is planned for mid-October.
Good:Farm, Canada’s first and largest outdoor organic cannabis facility, has the potential capacity to yield more than 40,000 kg of dried cannabis, at what 48North expects to be the lowest cost per gram in the country.
“Planting nearly 100 acres of organic cannabis outdoors was a significant accomplishment for the organization, relying on both established agricultural practices and innovative cannabis production techniques. Our team of expert farmers and growers ensured this ground-breaking task was a success,” said Jeannette VanderMarel, co-CEO of 48North.
48North has signed supply agreements for cannabis from its Good:Farm and other licensed production facilities, including:
- An historic outdoor cannabis agreement with the Société Québécoise du cannabis for 1,200 kg of dried cannabis;
- A supply agreement with the Alberta Gaming, Liquor and Cannabis agency for 2,460 kg of dried cannabis; and
- A supply agreement with the Ontario Cannabis Store for 1,200 kg of dried cannabis.
To bring Canadians along on this journey, 48North is hosting a bi-weekly web series on Good:Farm. “See the Good” focuses on the challenges, opportunities and lessons learned on the path cannabis takes from seed to sale.
Good:Farm has a number of strategic advantages, including ultra-low-cost cannabis as well as environment-friendly and energy-efficient production. In addition, the farm’s production will help address the current national shortage of recreational cannabis.
48North Cannabis Corp. (TSXV: NRTH) is a vertically integrated cannabis company focused on the health and wellness market through cultivation and extraction, as well as the creation of innovative, authentic brands for next-generation cannabis products. 48North is developing formulations and manufacturing capabilities for its own proprietary products, as well as positioning itself to contract manufacture similar products for third parties. 48North operates Good:Farm, a 100-acre organic cannabis farm that is expected to produce more than 40,000 kg of organic, sun-grown cannabis, securing a significant first-mover advantage in the production of low-cost, next-generation, extract-based cannabis products. In addition, 48North operates two indoor-licensed cannabis production sites in Ontario. 48North cultivates unique genetics at its wholly owned subsidiary, DelShen Therapeutics Corp. (“DelShen”) and processes cannabis and manufactures next-generation cannabis products at Good & Green Corp. (“Good & Green”), both Licensed Producers under the Cannabis Act. 48North has a growing portfolio of brands that include Latitude, a women’s cannabis platform (explorelatitude.com); Mother & Clone, a rapid-acting sublingual cannabis nanospray (momandclone.com); and Avitas, a single-strain vaporizer cartridge (avitasgrown.com).
DISCLAIMER & READER ADVISORY
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could,” “intend,” “expect,” “believe,” “will,” “projected,” “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Forward-looking statements in this news release include statements relating to the business plan and future operations of the Company. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including the possibility that the business plan described herein will not be completed, that 48North may not derive the expected benefits from such business plans, or that applicable regulatory approvals will be obtained to carry out the activities contemplated herein. The business of the Company is subject to a number of material risks and uncertainties. Please refer to the Company’s SEDAR filings for further details. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third-party approvals, and licensing and other risks associated with the Cannabis Act. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
SOURCE 48North Cannabis Corp.
Global Alliance for Cannabis Commerce Announces Nationwide “GACC Certified™” Testing and Purity Standards Program for Cannabis Products; Responds to Vape-Related Illness Outbreak
The Global Alliance for Cannabis Commerce (GACC), a trade organization representing a major cross-section of the global cannabis industry, today announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. It is expected by the end of 2020 this program will be available to all state-licensed cannabis operations. It gives licensed sellers and consumers confidence that the legal products that are approved under this program meet accepted safety and purity standards and are genuine. The standards and testing protocols are expected to meet or exceed the most stringent state standards currently in effect.
“Current laws make it impossible to assure the public that in every one of the 33 states where cannabis has been legalized, that there are uniform accepted standards for safety and purity even though consumers may well use legal product when in different states. Until federal law is corrected this problem will continue to exist,” said Randal John Meyer, Executive Director at GACC.
“GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide industry the tools to give this assurance. Members will have access to a coordinated national network of ISO certified laboratories that will use scientifically sound and accepted test methods to assure that cannabis meets the most appropriate safety and purity standards,” said GACC President Rezwan Khan. “By the end of next year, cannabis consumers will be able to look at a participating product anywhere in the United States that it is legally sold, see our blue leaf, and know if it meets the rigorous standard of GACC Certified™ consumer safety testing.”
GACC and each of its member companies believes that absent changes in federal law, it is incumbent on industry to establish consensus industry standards for safety and purity, and to create a serious and effective testing program.
Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020. The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.
All current GACC members have pledged to support the development of this standards setting protocol and to adopt and implement it as well when it is effective. This includes brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetics.
To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a new, membership class, the Standard Membership, that will involve minimal costs for participation, and that will provides access to the GACC Certified™ Program. Interested companies may inquire through the GACC website here: https://globalcannabiscommerce.org/gacc-certifiedtm/. GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories.
GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size. Cannabis has needed a voluntary unifying force for safety certification for years to increase consumer confidence in its products. Well, here it is—with a number of major cannabis brands already pledging widespread adoption.”
GACC has previously partnered with solo Sciences to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products. Through the partnership, solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology. “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine,” said GACC Executive Director Randal John Meyer.
SOURCE Global Alliance for Cannabis Commerce
Dixie Brands’ Wholly-Owned Subsidiary Secures Patent for Scientific Breakthrough in Cannabinoid Delivery
Dixie Brands Inc. (“Dixie” or “the Company”) (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV), one of the cannabis industry’s leading consumer packaged goods (“CPG”) companies, today announced that the United States Patent and Trademark Office will issue its wholly-owned subsidiary, Aceso Wellness, LLC (“Aceso”), a patent for a unique range of formats providing for the delivery of cannabinoids, along with nutrients, in effervescent powder and/or aqueous liquid forms.
The patent application, entitled ‘Cannabinoid Emulsion Product and Process for Making the Same’, encompasses a broad set of popular formats and formulations that provide for various nutraceutical compositions including cannabinoids, supplements and vitamins. These compositions have been configured for specific uses such as the promotion of the immune system, improved energy levels, joint and bone health, reduced inflammation, and more efficient cellular energy metabolism.
“This patent is the culmination of a 3-year process and demonstrates our commitment to, and investment in, the potential power of the inclusion of cannabinoids to help support healthy lifestyles.” says Jay Denniston C.F.S., Director of Science, Dixie Brands. “It provides proven, efficacious formats for consumers as they continue to explore cannabis as a plant-based, healthy alternative to traditional pharmaceutical products.”
The Company’s patented technology provides an extensive and protected platform to further access the burgeoning US Dietary Supplement market in addition to the rapidly emerging hemp-derived category. The US Dietary Supplement market is expected to grow to nearly US$57 billion by 2024 (Source: Matej Mikulic, Sep 19, 2019) lead by non-pill formats and fueled by increasing consumer awareness of nutrition, a focus on preventative health care and a desire for solutions that are perceived to be more natural.
“This is an incredibly exciting development for Dixie Brands, reflecting the depth of our R&D heritage, established over nearly a decade.” said Chuck Smith, President and CEO, Dixie Brands. “As the FDA provides positive guidance and the category continues to grow, securing patents for our scientific intellectual property not only provides protection for key elements of our portfolio and optimizes shareholder value but also further supports the continued legitimization and normalization of the cannabis industry.”
The patented technology has been commercialized by Aceso’s range of hemp-derived sprays, dissolvable tablets and powder sachets. The effervescent powder lies at the center of the company’s growth strategy in the hemp-derived CBD market due to the existing popularity of that format in the broader health and wellness category. The portfolio currently includes Calm, Soothe and Wellness variants and is available in more than 1,000 brick and mortar stores across the country. The breadth of the forthcoming patent protects the inclusion of cannabinoids in products across a broader range of formats and channels including the regulated cannabis marketplace.
SOURCE Dixie Brands, Inc.
Avicanna Receives DTC Eligibility for Common Shares on OTCQX
Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, is pleased to announce that it has obtained eligibility with the Depository Trust Company (“DTC“) for its common shares listed in the United States on the OTCQX® Best Market.
DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered to be “DTC eligible”. DTC eligibility is expected to simplify the process of trading the Company’s common shares on the OTCQX Best Market and enhance liquidity for U.S. Investors.
“With our common stock listed in the U.S. now DTC eligible, a greater number of brokerages and trading platforms will be able to manage trades in our shares. This increased accessibility for investors is expected to improve the liquidity of our shares, which will also help to attract more investors that are following the exciting momentum we are building in our business as we execute on our commercialization strategy,” stated Setu Purohit, President.
SOURCE Avicanna Inc.
Cannabis4 weeks ago
Supreme Cannabis First Quarter Earnings Release Scheduled for November 14, 2019
Cannabis4 weeks ago
Addressing THC Detox Myths and Facts
Cannabis4 weeks ago
Cannabis Can Treat Epileptic Seizures
Cannabis3 weeks ago
Khiron Launches Kuida Brand in the US, Begins First Sales
Cannabis4 weeks ago
Simplifya Takes the Guesswork Out of Cannabis M&A
Cannabis4 weeks ago
Mastercard partners with Tappy Technologies to Embed Payment Functionality into Fashion Wearables
Cannabis4 weeks ago
Medicinal cannabis company Cronos Australia makes ASX debut
Cannabis4 weeks ago
Empower Clinics Announces Record Preliminary Unaudited Q3 2019 Revenue with 138% year over year increase and Details for Release of Financial Statements